Related Experiment Videos
The insulin-like growth factor axis in cell cycle progression.
J Dupont1, A Pierre, P Froment
1Unité de Physiologie de la Reproduction et des Comportements, Institut National de la Recherche Agronomique, Nouzilly, France. jdupont@tours.inra.fr
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|January 8, 2004
Summary
The Insulin-like Growth Factors (IGFs) system, including IGF-I, IGF-II, and IGF-binding proteins, is crucial in cancer development. This review details how IGFs regulate cell cycle progression in cancer.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- The Insulin-like Growth Factors (IGFs) system is implicated in cancer development and progression.
- Cancer cells display deregulated proliferation and cell cycle abnormalities.
- IGFs, including IGF-I, IGF-II, IGF-IR, and IGFBPs, are key players in these processes.
Purpose of the Study:
- To review the role of the IGF system in regulating cell cycle components.
- To elucidate the molecular mechanisms of IGF-mediated cell cycle control in cancer.
Main Methods:
- Literature review of emerging evidence.
- Analysis of molecular mechanisms linking IGFs to cell cycle regulation.
Main Results:
- IGFs play a central role in cancer cell proliferation.
- The IGF system influences key regulators of the cell cycle.
- Abnormalities in IGF signaling contribute to cancer progression.
Conclusions:
- The IGF system is a significant regulator of cell cycle progression in cancer.
- Understanding IGFs' role in cell cycle control offers potential therapeutic targets.